Moderna, Merck say vaccine improved survival in patients with deadly skin cancer CNBCAn mRNA Melanoma Vaccine Shows Promise | TIME TIMEMerck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial MarketWatchMerck’s 3-pronged cancer strategy stars Moderna-partnered vaccine Fierce BiotechMelanoma vaccine lowers death, reoccurrence risk by 49 per cent, trial finds 9News